Wednesday, May 9, 2012

FDA panel urges approval for Pfizer arthritis drug

FDA urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant PfizerAn advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.


Click here to read the rest

No comments:

Post a Comment